| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Mechanics | 27 | 2022 | 699 | 4.740 |
Why?
|
| Bronchial Hyperreactivity | 11 | 2017 | 302 | 3.070 |
Why?
|
| Anesthesia | 21 | 2024 | 1592 | 2.940 |
Why?
|
| Lung | 45 | 2024 | 9994 | 2.870 |
Why?
|
| Bronchoconstriction | 10 | 2023 | 142 | 2.450 |
Why?
|
| Lung Volume Measurements | 13 | 2020 | 375 | 2.170 |
Why?
|
| Respiration, Artificial | 18 | 2024 | 2625 | 2.050 |
Why?
|
| Airway Resistance | 22 | 2019 | 406 | 2.020 |
Why?
|
| Pulmonary Surfactants | 5 | 2015 | 162 | 1.840 |
Why?
|
| Anesthesia, General | 16 | 2023 | 1174 | 1.800 |
Why?
|
| Pulmonary Gas Exchange | 8 | 2022 | 379 | 1.750 |
Why?
|
| Methyl Ethers | 6 | 2018 | 196 | 1.680 |
Why?
|
| Positive-Pressure Respiration | 13 | 2023 | 639 | 1.610 |
Why?
|
| Pulmonary Circulation | 10 | 2016 | 743 | 1.510 |
Why?
|
| Anesthetics, Inhalation | 8 | 2013 | 574 | 1.430 |
Why?
|
| Rabbits | 25 | 2024 | 4779 | 1.430 |
Why?
|
| Methacholine Chloride | 10 | 2017 | 220 | 1.280 |
Why?
|
| Anesthesia, Conduction | 2 | 2023 | 262 | 1.210 |
Why?
|
| Ovalbumin | 7 | 2018 | 676 | 1.190 |
Why?
|
| High-Frequency Ventilation | 3 | 2024 | 88 | 1.100 |
Why?
|
| Pulmonary Atelectasis | 4 | 2023 | 143 | 1.090 |
Why?
|
| Intraoperative Complications | 7 | 2021 | 1165 | 0.940 |
Why?
|
| Bronchoconstrictor Agents | 6 | 2017 | 77 | 0.910 |
Why?
|
| Respiration Disorders | 4 | 2013 | 367 | 0.910 |
Why?
|
| Synchrotrons | 5 | 2023 | 39 | 0.880 |
Why?
|
| Asthma | 8 | 2023 | 6210 | 0.880 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 2014 | 180 | 0.840 |
Why?
|
| Airway Management | 6 | 2023 | 312 | 0.820 |
Why?
|
| Ephedrine | 1 | 2022 | 52 | 0.820 |
Why?
|
| Acute Lung Injury | 2 | 2016 | 367 | 0.800 |
Why?
|
| Hypertension, Pulmonary | 6 | 2015 | 1580 | 0.780 |
Why?
|
| Blood Volume | 3 | 2018 | 548 | 0.760 |
Why?
|
| Isoflurane | 4 | 2011 | 384 | 0.720 |
Why?
|
| Iodine | 1 | 2023 | 288 | 0.720 |
Why?
|
| Hernia, Inguinal | 1 | 2023 | 220 | 0.710 |
Why?
|
| Anesthesia, Spinal | 1 | 2023 | 280 | 0.700 |
Why?
|
| Respiratory Function Tests | 9 | 2019 | 1682 | 0.680 |
Why?
|
| Cytomegalovirus Infections | 2 | 2024 | 831 | 0.670 |
Why?
|
| Allergens | 5 | 2018 | 1410 | 0.660 |
Why?
|
| Anesthetics | 3 | 2021 | 523 | 0.650 |
Why?
|
| Neuromuscular Blocking Agents | 3 | 2013 | 129 | 0.650 |
Why?
|
| Hyperoxia | 2 | 2014 | 258 | 0.630 |
Why?
|
| Functional Residual Capacity | 5 | 2019 | 70 | 0.610 |
Why?
|
| Carbon Dioxide | 7 | 2024 | 1146 | 0.600 |
Why?
|
| Disease Models, Animal | 13 | 2020 | 18234 | 0.600 |
Why?
|
| Hemodilution | 1 | 2018 | 120 | 0.590 |
Why?
|
| Pyroglyphidae | 1 | 2017 | 88 | 0.570 |
Why?
|
| Elasticity | 4 | 2016 | 655 | 0.560 |
Why?
|
| Infant, Newborn | 20 | 2023 | 26211 | 0.550 |
Why?
|
| Bronchial Provocation Tests | 4 | 2012 | 216 | 0.550 |
Why?
|
| Choline | 1 | 2018 | 514 | 0.540 |
Why?
|
| Oxygen | 9 | 2022 | 4227 | 0.540 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2019 | 8166 | 0.530 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2019 | 410 | 0.520 |
Why?
|
| Vascular Resistance | 6 | 2016 | 932 | 0.510 |
Why?
|
| Respiratory Tract Infections | 5 | 2010 | 1010 | 0.510 |
Why?
|
| Animals | 58 | 2024 | 168388 | 0.510 |
Why?
|
| Pediatrics | 8 | 2024 | 3594 | 0.510 |
Why?
|
| Albuterol | 3 | 2023 | 213 | 0.490 |
Why?
|
| Intraoperative Care | 1 | 2019 | 766 | 0.490 |
Why?
|
| Perioperative Period | 1 | 2016 | 249 | 0.480 |
Why?
|
| Tidal Volume | 1 | 2016 | 488 | 0.460 |
Why?
|
| Rats | 22 | 2019 | 23729 | 0.460 |
Why?
|
| Infant | 28 | 2023 | 36202 | 0.460 |
Why?
|
| Receptors, Muscarinic | 2 | 2018 | 157 | 0.460 |
Why?
|
| Models, Animal | 2 | 2018 | 2112 | 0.450 |
Why?
|
| Blood Pressure | 10 | 2018 | 8485 | 0.450 |
Why?
|
| Anesthesiology | 5 | 2024 | 1117 | 0.450 |
Why?
|
| Bone Marrow | 1 | 2024 | 2909 | 0.440 |
Why?
|
| Awareness | 2 | 2009 | 647 | 0.440 |
Why?
|
| Laryngeal Masks | 2 | 2019 | 101 | 0.440 |
Why?
|
| Child | 42 | 2024 | 80156 | 0.430 |
Why?
|
| Ventilators, Mechanical | 3 | 2021 | 288 | 0.420 |
Why?
|
| Preanesthetic Medication | 3 | 2009 | 48 | 0.420 |
Why?
|
| Postoperative Complications | 10 | 2024 | 15647 | 0.420 |
Why?
|
| Tomography, Spiral Computed | 1 | 2014 | 273 | 0.420 |
Why?
|
| Europe | 8 | 2022 | 3420 | 0.410 |
Why?
|
| Pulmonary Ventilation | 4 | 2023 | 372 | 0.410 |
Why?
|
| Intubation, Intratracheal | 9 | 2023 | 1329 | 0.410 |
Why?
|
| Respiration | 4 | 2023 | 1657 | 0.400 |
Why?
|
| Helium | 3 | 2020 | 119 | 0.390 |
Why?
|
| Adenoidectomy | 1 | 2013 | 167 | 0.390 |
Why?
|
| Heart Rate | 2 | 2018 | 4197 | 0.390 |
Why?
|
| Pneumonia | 2 | 2020 | 2140 | 0.380 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 748 | 0.380 |
Why?
|
| Muscarinic Agonists | 1 | 2011 | 91 | 0.380 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2018 | 128 | 0.370 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.370 |
Why?
|
| Microcirculation | 3 | 2022 | 1269 | 0.370 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 702 | 0.350 |
Why?
|
| Histamine | 4 | 2008 | 497 | 0.350 |
Why?
|
| Heart Defects, Congenital | 4 | 2019 | 4696 | 0.350 |
Why?
|
| Pneumoperitoneum | 2 | 2020 | 46 | 0.350 |
Why?
|
| Tonsillectomy | 1 | 2013 | 277 | 0.350 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2013 | 356 | 0.350 |
Why?
|
| Acetaminophen | 1 | 2014 | 554 | 0.340 |
Why?
|
| Antihypertensive Agents | 2 | 2011 | 2023 | 0.340 |
Why?
|
| Oscillometry | 2 | 2010 | 150 | 0.340 |
Why?
|
| Hypnosis, Anesthetic | 1 | 2009 | 7 | 0.330 |
Why?
|
| Shock, Hemorrhagic | 1 | 2011 | 223 | 0.330 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 694 | 0.330 |
Why?
|
| Preoperative Care | 3 | 2023 | 2242 | 0.330 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2009 | 58 | 0.330 |
Why?
|
| Lung Diseases | 4 | 2008 | 1909 | 0.330 |
Why?
|
| Receptors, Histamine | 1 | 2008 | 23 | 0.320 |
Why?
|
| Vasodilator Agents | 2 | 2011 | 973 | 0.320 |
Why?
|
| Child, Preschool | 25 | 2019 | 42251 | 0.320 |
Why?
|
| Anesthetics, General | 1 | 2010 | 151 | 0.320 |
Why?
|
| Laryngismus | 5 | 2013 | 29 | 0.310 |
Why?
|
| Anesthetics, Intravenous | 3 | 2013 | 396 | 0.310 |
Why?
|
| Midazolam | 3 | 2009 | 266 | 0.310 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2009 | 273 | 0.300 |
Why?
|
| Endothelin-1 | 2 | 2008 | 302 | 0.300 |
Why?
|
| Drug Hypersensitivity | 1 | 2017 | 917 | 0.300 |
Why?
|
| Bronchial Spasm | 4 | 2013 | 71 | 0.290 |
Why?
|
| Eye Diseases | 1 | 2013 | 655 | 0.290 |
Why?
|
| Mitral Valve | 1 | 2016 | 1471 | 0.290 |
Why?
|
| General Surgery | 1 | 2019 | 1692 | 0.290 |
Why?
|
| Hemodynamics | 6 | 2021 | 4167 | 0.290 |
Why?
|
| Halothane | 1 | 2007 | 200 | 0.280 |
Why?
|
| Male | 60 | 2023 | 360621 | 0.280 |
Why?
|
| Mythology | 1 | 2006 | 15 | 0.270 |
Why?
|
| Hypersensitivity | 2 | 2013 | 1158 | 0.270 |
Why?
|
| Pulmonary Alveoli | 3 | 2013 | 650 | 0.270 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2016 | 1404 | 0.270 |
Why?
|
| Piperazines | 2 | 2014 | 2519 | 0.270 |
Why?
|
| Wakefulness | 1 | 2013 | 1265 | 0.270 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1665 | 0.270 |
Why?
|
| Laryngoscopy | 2 | 2022 | 706 | 0.270 |
Why?
|
| Anesthetics, Local | 4 | 2019 | 997 | 0.270 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2006 | 27 | 0.270 |
Why?
|
| Child Behavior Disorders | 2 | 2019 | 804 | 0.260 |
Why?
|
| Peptides, Cyclic | 1 | 2008 | 392 | 0.260 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1517 | 0.260 |
Why?
|
| Biological Products | 1 | 2015 | 913 | 0.260 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1212 | 0.250 |
Why?
|
| Tramadol | 2 | 2021 | 60 | 0.250 |
Why?
|
| Humans | 72 | 2024 | 761326 | 0.250 |
Why?
|
| Tetralogy of Fallot | 1 | 2011 | 631 | 0.250 |
Why?
|
| Cardiac Output | 3 | 2022 | 837 | 0.240 |
Why?
|
| Respiratory System | 1 | 2008 | 563 | 0.240 |
Why?
|
| Sulfonamides | 1 | 2014 | 1976 | 0.240 |
Why?
|
| Analysis of Variance | 6 | 2013 | 6231 | 0.230 |
Why?
|
| Prospective Studies | 20 | 2023 | 54405 | 0.230 |
Why?
|
| Histamine H1 Antagonists | 1 | 2004 | 100 | 0.230 |
Why?
|
| Postoperative Period | 2 | 2019 | 1813 | 0.230 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 527 | 0.230 |
Why?
|
| Animals, Newborn | 2 | 2020 | 2678 | 0.220 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 2082 | 0.220 |
Why?
|
| Cough | 4 | 2013 | 594 | 0.220 |
Why?
|
| Fluid Therapy | 2 | 2019 | 581 | 0.220 |
Why?
|
| Lung Compliance | 3 | 2009 | 200 | 0.220 |
Why?
|
| Swine | 4 | 2022 | 5915 | 0.220 |
Why?
|
| Insufflation | 2 | 2020 | 61 | 0.210 |
Why?
|
| Inhalation | 2 | 2017 | 143 | 0.210 |
Why?
|
| Bronchodilator Agents | 2 | 2019 | 512 | 0.210 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2022 | 11 | 0.210 |
Why?
|
| Pneumonia, Aspiration | 1 | 2023 | 145 | 0.210 |
Why?
|
| Oligopeptides | 1 | 2008 | 1186 | 0.210 |
Why?
|
| Incidence | 8 | 2024 | 21336 | 0.210 |
Why?
|
| Fractals | 1 | 2023 | 128 | 0.200 |
Why?
|
| Spinal Puncture | 1 | 2024 | 282 | 0.200 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 2727 | 0.200 |
Why?
|
| Myocardial Ischemia | 2 | 2012 | 2110 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2119 | 0.190 |
Why?
|
| Lactates | 1 | 2022 | 405 | 0.190 |
Why?
|
| Health Status | 3 | 2021 | 4075 | 0.190 |
Why?
|
| Bronchi | 3 | 2013 | 845 | 0.180 |
Why?
|
| Laryngoscopes | 1 | 2022 | 146 | 0.180 |
Why?
|
| Propofol | 2 | 2006 | 603 | 0.180 |
Why?
|
| Female | 38 | 2023 | 392485 | 0.180 |
Why?
|
| Random Allocation | 4 | 2019 | 2389 | 0.180 |
Why?
|
| Isoquinolines | 3 | 2008 | 352 | 0.170 |
Why?
|
| Age Factors | 6 | 2021 | 18401 | 0.170 |
Why?
|
| Peritoneal Cavity | 1 | 2020 | 135 | 0.170 |
Why?
|
| Hypercapnia | 1 | 2021 | 261 | 0.170 |
Why?
|
| Pressure | 2 | 2016 | 1155 | 0.170 |
Why?
|
| Memory | 1 | 2009 | 2187 | 0.170 |
Why?
|
| Piperidines | 1 | 2008 | 1657 | 0.170 |
Why?
|
| Isotonic Solutions | 2 | 2019 | 117 | 0.170 |
Why?
|
| Purines | 2 | 2014 | 605 | 0.170 |
Why?
|
| Moyamoya Disease | 1 | 2003 | 265 | 0.160 |
Why?
|
| Cholinergic Agents | 1 | 2019 | 96 | 0.160 |
Why?
|
| Capnography | 2 | 2022 | 91 | 0.160 |
Why?
|
| Receptors, Endothelin | 2 | 2011 | 56 | 0.160 |
Why?
|
| Ventricular Function, Left | 2 | 2012 | 3878 | 0.160 |
Why?
|
| Dexmedetomidine | 1 | 2023 | 319 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 654 | 0.160 |
Why?
|
| Administration, Inhalation | 3 | 2010 | 1156 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 10764 | 0.150 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 211 | 0.150 |
Why?
|
| Adolescent | 13 | 2019 | 88305 | 0.150 |
Why?
|
| Risk Factors | 12 | 2021 | 74152 | 0.150 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 505 | 0.150 |
Why?
|
| Airway Obstruction | 3 | 2013 | 661 | 0.150 |
Why?
|
| Muscarinic Antagonists | 1 | 2018 | 135 | 0.150 |
Why?
|
| Succinylcholine | 2 | 2008 | 66 | 0.150 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2009 | 1094 | 0.140 |
Why?
|
| Thoracic Wall | 1 | 2019 | 202 | 0.140 |
Why?
|
| Anesthesia, Local | 1 | 2019 | 277 | 0.140 |
Why?
|
| Cerebral Angiography | 1 | 2003 | 1281 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2022 | 565 | 0.140 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2009 | 3630 | 0.140 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 1737 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 8997 | 0.130 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 539 | 0.130 |
Why?
|
| Respiratory Insufficiency | 2 | 2024 | 1230 | 0.130 |
Why?
|
| Swine, Miniature | 1 | 2018 | 961 | 0.130 |
Why?
|
| Instillation, Drug | 1 | 2015 | 32 | 0.130 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 324 | 0.130 |
Why?
|
| Viscosity | 1 | 2016 | 336 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 754 | 0.120 |
Why?
|
| Infusions, Intravenous | 2 | 2010 | 2217 | 0.120 |
Why?
|
| Dopamine | 1 | 2022 | 1605 | 0.120 |
Why?
|
| Hematocrit | 1 | 2016 | 625 | 0.120 |
Why?
|
| Perfusion | 4 | 2008 | 1374 | 0.120 |
Why?
|
| Lung Injury | 1 | 2019 | 422 | 0.120 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2014 | 144 | 0.120 |
Why?
|
| Resuscitation | 1 | 2019 | 673 | 0.120 |
Why?
|
| Risk Assessment | 7 | 2023 | 23981 | 0.110 |
Why?
|
| Therapeutic Irrigation | 1 | 2015 | 292 | 0.110 |
Why?
|
| Anesthesia, Inhalation | 2 | 2021 | 220 | 0.110 |
Why?
|
| Fentanyl | 1 | 2017 | 435 | 0.110 |
Why?
|
| Vitreoretinal Surgery | 1 | 2013 | 28 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 926 | 0.110 |
Why?
|
| Child Behavior | 1 | 2019 | 847 | 0.110 |
Why?
|
| Mucociliary Clearance | 1 | 2013 | 80 | 0.110 |
Why?
|
| Tetrazoles | 2 | 2011 | 910 | 0.100 |
Why?
|
| Acetylcholine | 2 | 2019 | 628 | 0.100 |
Why?
|
| Plethysmography | 1 | 2012 | 175 | 0.100 |
Why?
|
| Nerve Block | 1 | 2019 | 705 | 0.100 |
Why?
|
| Medical Audit | 3 | 2021 | 453 | 0.100 |
Why?
|
| Time Factors | 8 | 2021 | 39974 | 0.100 |
Why?
|
| Emergency Treatment | 1 | 2016 | 496 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6210 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 636 | 0.100 |
Why?
|
| Thoracic Injuries | 1 | 1994 | 288 | 0.100 |
Why?
|
| Iloprost | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15499 | 0.100 |
Why?
|
| Laparoscopy | 2 | 2020 | 2035 | 0.100 |
Why?
|
| Prostaglandins I | 1 | 2011 | 13 | 0.100 |
Why?
|
| Brain | 3 | 2019 | 27103 | 0.100 |
Why?
|
| Endothelins | 1 | 2011 | 127 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 20555 | 0.090 |
Why?
|
| Infusions, Parenteral | 1 | 2011 | 398 | 0.090 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2011 | 158 | 0.090 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2011 | 101 | 0.090 |
Why?
|
| Catecholamines | 1 | 2011 | 386 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 79 | 0.090 |
Why?
|
| Endocarditis, Bacterial | 1 | 1994 | 444 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2023 | 12329 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1994 | 579 | 0.090 |
Why?
|
| Parasympathomimetics | 1 | 2009 | 27 | 0.090 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 3801 | 0.080 |
Why?
|
| Diuretics | 1 | 2012 | 610 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 1923 | 0.080 |
Why?
|
| Prilocaine | 1 | 2009 | 21 | 0.080 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2008 | 15 | 0.080 |
Why?
|
| Atracurium | 1 | 2008 | 51 | 0.080 |
Why?
|
| Cataract Extraction | 1 | 2013 | 467 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2024 | 3800 | 0.080 |
Why?
|
| Buprenorphine | 1 | 2017 | 655 | 0.080 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2008 | 37 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2011 | 23427 | 0.080 |
Why?
|
| Tomography, X-Ray | 1 | 2008 | 60 | 0.080 |
Why?
|
| Receptor, Endothelin A | 1 | 2008 | 56 | 0.080 |
Why?
|
| Sulfones | 1 | 2011 | 447 | 0.080 |
Why?
|
| Refractometry | 1 | 2008 | 57 | 0.080 |
Why?
|
| Receptor, Endothelin B | 1 | 2008 | 46 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 1 | 1994 | 1088 | 0.080 |
Why?
|
| Dendritic Spines | 1 | 2010 | 243 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2009 | 344 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2010 | 1461 | 0.070 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2008 | 116 | 0.070 |
Why?
|
| Potassium Channels | 1 | 2010 | 537 | 0.070 |
Why?
|
| Atropine | 1 | 2007 | 244 | 0.070 |
Why?
|
| Pipecuronium | 1 | 2006 | 6 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2013 | 996 | 0.070 |
Why?
|
| Pyridines | 2 | 2011 | 2870 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2010 | 773 | 0.070 |
Why?
|
| Critical Care | 3 | 2023 | 2697 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 901 | 0.070 |
Why?
|
| Lentivirus | 1 | 2009 | 508 | 0.070 |
Why?
|
| Organ Size | 2 | 2009 | 2252 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2010 | 701 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 617 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2021 | 64645 | 0.070 |
Why?
|
| Cross-Over Studies | 2 | 2022 | 2075 | 0.070 |
Why?
|
| Lidocaine | 1 | 2009 | 538 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 665 | 0.060 |
Why?
|
| Vasoconstriction | 1 | 2008 | 592 | 0.060 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2010 | 575 | 0.060 |
Why?
|
| Ipratropium | 1 | 2004 | 19 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3356 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2022 | 1524 | 0.060 |
Why?
|
| Analgesia, Epidural | 1 | 2008 | 332 | 0.060 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2006 | 273 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2010 | 818 | 0.060 |
Why?
|
| Bupivacaine | 1 | 2008 | 412 | 0.060 |
Why?
|
| Adrenergic Agonists | 1 | 2004 | 58 | 0.060 |
Why?
|
| Cromolyn Sodium | 1 | 2004 | 77 | 0.060 |
Why?
|
| Australia | 1 | 2007 | 1246 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 698 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1938 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3687 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7954 | 0.060 |
Why?
|
| Heart Atria | 1 | 2010 | 1346 | 0.060 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2004 | 111 | 0.060 |
Why?
|
| Glaucoma | 1 | 2013 | 1185 | 0.050 |
Why?
|
| Hospitals | 1 | 2017 | 3878 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2004 | 168 | 0.050 |
Why?
|
| Serotonin | 1 | 2008 | 1041 | 0.050 |
Why?
|
| Child Development | 1 | 2015 | 2304 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2011 | 4013 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2007 | 773 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1780 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2004 | 1317 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6309 | 0.050 |
Why?
|
| Androstadienes | 1 | 2004 | 348 | 0.050 |
Why?
|
| Respiratory Aspiration | 1 | 2023 | 89 | 0.050 |
Why?
|
| Cytokines | 1 | 2017 | 7390 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2009 | 1232 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2133 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1301 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 1516 | 0.050 |
Why?
|
| Supine Position | 1 | 2022 | 205 | 0.050 |
Why?
|
| Calcitonin | 1 | 2003 | 329 | 0.050 |
Why?
|
| Histamine Antagonists | 1 | 2002 | 90 | 0.050 |
Why?
|
| Rupture | 1 | 2003 | 443 | 0.050 |
Why?
|
| Reference Values | 1 | 2008 | 4921 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 477 | 0.050 |
Why?
|
| Respiratory Muscles | 1 | 2002 | 142 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 2751 | 0.050 |
Why?
|
| Prone Position | 1 | 2022 | 196 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2013 | 3425 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2019 | 1846 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4793 | 0.050 |
Why?
|
| Body Weight | 2 | 2009 | 4614 | 0.050 |
Why?
|
| Death | 1 | 2006 | 676 | 0.050 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2002 | 141 | 0.050 |
Why?
|
| Algorithms | 4 | 2013 | 14025 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 494 | 0.050 |
Why?
|
| Switzerland | 1 | 2021 | 324 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 941 | 0.050 |
Why?
|
| Acute Disease | 1 | 2011 | 7238 | 0.040 |
Why?
|
| Synapses | 1 | 2010 | 1769 | 0.040 |
Why?
|
| Vomiting | 1 | 2023 | 652 | 0.040 |
Why?
|
| Models, Biological | 3 | 2010 | 9468 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 2008 | 1037 | 0.040 |
Why?
|
| Research Design | 1 | 2016 | 6178 | 0.040 |
Why?
|
| Comorbidity | 2 | 2021 | 10498 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2004 | 1415 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
| Dobutamine | 1 | 2019 | 116 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 26108 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 2219 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 2 | 2023 | 1178 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 1723 | 0.040 |
Why?
|
| Blood Substitutes | 1 | 2019 | 57 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2003 | 1134 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2007 | 1490 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15835 | 0.040 |
Why?
|
| Oximetry | 1 | 2021 | 460 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2019 | 379 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2013 | 4813 | 0.040 |
Why?
|
| Fasting | 1 | 2023 | 1602 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2019 | 794 | 0.040 |
Why?
|
| Trachea | 1 | 2003 | 1089 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2010 | 2785 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2008 | 3094 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2007 | 1287 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 7045 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2021 | 740 | 0.030 |
Why?
|
| Plasma Substitutes | 1 | 2016 | 57 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39108 | 0.030 |
Why?
|
| Colloids | 1 | 2016 | 122 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2007 | 9639 | 0.030 |
Why?
|
| Data Collection | 1 | 2024 | 3324 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 1809 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 713 | 0.030 |
Why?
|
| Brachiocephalic Trunk | 1 | 1994 | 40 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2007 | 6382 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2013 | 69 | 0.030 |
Why?
|
| Smoking | 1 | 2010 | 9051 | 0.030 |
Why?
|
| Methylene Blue | 1 | 2013 | 155 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2003 | 3210 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 3576 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2003 | 2071 | 0.020 |
Why?
|
| Multiple Trauma | 1 | 1994 | 369 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2021 | 2104 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 1994 | 319 | 0.020 |
Why?
|
| Stents | 1 | 2003 | 3179 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2003 | 3824 | 0.020 |
Why?
|
| Aneurysm | 1 | 1994 | 337 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2021 | 3552 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 2010 | 138 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1994 | 523 | 0.020 |
Why?
|
| Iontophoresis | 1 | 2010 | 74 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2010 | 235 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 7389 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2010 | 383 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2010 | 194 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2010 | 211 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3322 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7999 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2009 | 286 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 609 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2009 | 252 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3025 | 0.020 |
Why?
|
| Eosinophils | 1 | 2013 | 947 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5247 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5077 | 0.020 |
Why?
|
| Constriction | 1 | 2007 | 171 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 22154 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 369 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2010 | 559 | 0.020 |
Why?
|
| Cognition | 1 | 2005 | 6987 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2009 | 903 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 626 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2003 | 6224 | 0.020 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2008 | 128 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2010 | 546 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2010 | 459 | 0.020 |
Why?
|
| Crying | 1 | 2006 | 37 | 0.020 |
Why?
|
| Population | 1 | 2006 | 141 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 81474 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6236 | 0.020 |
Why?
|
| Simplexvirus | 1 | 2009 | 803 | 0.020 |
Why?
|
| Gastric Emptying | 1 | 2007 | 242 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2009 | 719 | 0.010 |
Why?
|
| Cell Death | 1 | 2010 | 1674 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10203 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4571 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 876 | 0.010 |
Why?
|
| Troponin I | 1 | 2008 | 651 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 11672 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2009 | 3097 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4567 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 1612 | 0.010 |
Why?
|
| Bronchial Diseases | 1 | 2003 | 150 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2003 | 249 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2853 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2009 | 1803 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5034 | 0.010 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1222 | 0.010 |
Why?
|
| Scoliosis | 1 | 2008 | 740 | 0.010 |
Why?
|
| Tracheal Stenosis | 1 | 2003 | 228 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 41440 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2009 | 1296 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2003 | 323 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3572 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6086 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 2042 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 3393 | 0.010 |
Why?
|
| Movement | 1 | 2006 | 1478 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 12972 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2002 | 409 | 0.010 |
Why?
|
| Adult | 3 | 2023 | 221122 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 58946 | 0.010 |
Why?
|
| Nurses | 1 | 2007 | 2478 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 2498 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2009 | 3057 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2691 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11070 | 0.010 |
Why?
|
| Echocardiography | 1 | 2008 | 4991 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15599 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3510 | 0.010 |
Why?
|
| Temperature | 1 | 2002 | 2229 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12787 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 4063 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80575 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 18962 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 10760 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 1427 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14665 | 0.010 |
Why?
|
| Reoperation | 1 | 2003 | 4302 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 11900 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2006 | 5078 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12059 | 0.010 |
Why?
|
| Aged | 1 | 2023 | 169179 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20092 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15262 | 0.010 |
Why?
|